BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

IBRNvsGNOMETF Comparison

ETF 1

IBRN

iShares Neuroscience and Healthcare ETF

This fund is part of

Healthcare Technology

-0.05%

Full IBRN fund page

VS

ETF 2

GNOM

Global X Genomics & Biotechnology ETF

This fund is part of

BioTech & Genomics

-0.43%

Full GNOM fund page

iShares Neuroscience and Healthcare ETF (IBRN) belongs to the Healthcare Technology segment. Global X Genomics & Biotechnology ETF (GNOM) is part of the BioTech & Genomics segment. IBRN's top 2 sector exposures are Healthcare and Non-Corporate. IBRN is less expensive with a Total Expense Ratio (TER) of 0.47%, versus 0.5% for GNOM. IBRN is up 20.57% year-to-date (YTD) with +$2M in YTD flows. GNOM performs better with 42.54% YTD performance, and +$16M in YTD flows. Run a side-by-side ETF comparison of IBRN and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

IBRN vs GNOM performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 09/01/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	IBRN GNOM	+6.36%+18.42%	+10.03%+33.63%	+20.57%+42.54%	+55.97%+77.94%	+69.91%+44.48%	n/a-32.82%
Flows	IBRN GNOM	+$2M-$3M	+$2M+$16M	+$2M+$16M	+$2M+$10M	+$759K-$59M	--$37M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	IBRN GNOM	+26.38%+39.29%	+25.83%+30.63%	+25.21%+30.39%	n/a+33.85%
Max drawdown	IBRN GNOM	-9.28%-8.57%	-9.28%-18.16%	-34.98%-43.10%	n/a-72.01%
Max drawdown duration	IBRN GNOM	40d32d	40d145d	338d674d	n/a1825d

Trading data

Create an account to view trading data

Join for free

	IBRN	GNOM
Last sale 9/2/2026 at 1:30 PM	$39.46	$65.68
Previous close 09/01/2026	$38.94	$64.76
Consolidated volume 09/01/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of August 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	IBRN	GNOM
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 9/2/2026 at 1:30 PM

Live

Closed

	IBRN	GNOM
Last price	$39.46	$65.68
1D performance	+1.33%	+1.42%
AuM	$7.79 M	$92.38 M
E/R	0.47%	0.5%

Characteristics

	IBRN	GNOM
Management strategy	Passive	Passive
Provider	iShares	Global X
Benchmark	NYSE FactSet Global Neuro Biopharma and MedTech Index	Solactive Genomics Index
N° of holdings	69	-
Asset class	Equities	Equities
Trailing 12m distribution yield	Join	Join
Inception date	August 24, 2022	April 5, 2019
ESG	No	No

More IBRN data on Trackinsight

More GNOM data on Trackinsight

Exposure

Countries

IBRN

USA

73.57%

Other

26.43%

GNOM

Data will be available soon

Sectors

IBRN

Healthcare

99.87%

Other

0.13%

GNOM

Data will be available soon

Diversification

IBRN

Total weight of top 15 holdings out of 15

64.26%

GNOM

Data will be available soon

Top 15 holdings

Data as of July 31, 2026

IBRN

Dianthus Therapeutics, Inc.

5.45%

Xenon Pharmaceuticals, Inc.

4.83%

Praxis Precision Medicines, Inc.

4.72%

ACADIA Pharmaceuticals, Inc.

4.66%

Arrowhead Pharmaceuticals, Inc.

4.65%

Alkermes Plc

4.55%

Neurocrine Biosciences, Inc.

4.41%

Scholar Rock Holding Corp.

4.31%

PTC Therapeutics, Inc.

4.15%

Biogen, Inc.

4.15%

Axsome Therapeutics, Inc.

3.93%

argenx SE

3.82%

Denali Therapeutics, Inc.

3.76%

Dyne Therapeutics, Inc.

3.53%

Edgewise Therapeutics, Inc.

3.35%

GNOM

Data will be available soon

Frequently asked questions about IBRN and GNOM

IBRNvsGNOMETF Comparison

iShares Neuroscience and Healthcare ETF

Global X Genomics & Biotechnology ETF

IBRN vs GNOM performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the IBRN and GNOM ETFs performed in 2026?

As of September 1, 2026, IBRN is up 20.57% year-to-date (YTD), while GNOM has returned 42.54%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: IBRN or GNOM?

Year-to-date, the IBRN ETF saw +$2M in flows, compared to +$16M for GNOM.

Which ETF is more volatile: IBRN or GNOM?

Over the past year, IBRN had a volatility of 25.83%, while GNOM experienced 30.63%.

Which ETF is bigger: IBRN or GNOM?

As of September 1, 2026, IBRN holds $7.79 M in assets under management (AUM), while GNOM manages $92.38 M.

Expert-Built ETF Portfolios, All in One Place